181 related articles for article (PubMed ID: 4152781)
21. An antigenic determinant of cytotoxic lymphocytes.
Sullivan KA; Berke G; Amos DB
Transplantation; 1973 Oct; 16(4):388-91. PubMed ID: 4126790
[No Abstract] [Full Text] [Related]
22. Thymus: an essential factor in lymphoid repopulation.
Stutman O; Yunis EJ; Good RA
Transplant Proc; 1969 Mar; 1(1):614-5. PubMed ID: 4400068
[No Abstract] [Full Text] [Related]
23. Role of T lymphocytes in the humoral immune response. I. Proliferation of B lymphocytes in thymus-deprived mice.
Davie JM; Paul WE
J Immunol; 1974 Nov; 113(5):1438-45. PubMed ID: 4138070
[No Abstract] [Full Text] [Related]
24. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
Norin AJ; Emeson EE
J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
[TBL] [Abstract][Full Text] [Related]
25. Receptors for immunoglobulin on B lymphocytes and cells of a cultured plasma cell tumor.
Cline MJ; Sprent J; Warner NL; Harris AW
J Immunol; 1972 Apr; 108(4):1126-8. PubMed ID: 4554011
[No Abstract] [Full Text] [Related]
26. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
[TBL] [Abstract][Full Text] [Related]
27. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.
Gorczynski RM
J Immunol; 1974 Feb; 112(2):533-9. PubMed ID: 4360545
[No Abstract] [Full Text] [Related]
28. Differential inactivation of lymphocytes and bone marrow stem cells by heterologous anti-mouse gamma-globulin serum.
Cole LJ; Maki SE
Nat New Biol; 1971 Apr; 230(16):244-6. PubMed ID: 4396811
[No Abstract] [Full Text] [Related]
29. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
Norin AJ; Emeson EE; Veith FJ
J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
[TBL] [Abstract][Full Text] [Related]
30. Antibodies specific for the theta- and Ly-alloantigens in various rabbit antisera.
Rabinowitz R; Cohen A; Laskov R; Schlesinger M
J Immunol; 1974 Feb; 112(2):683-92. PubMed ID: 4405954
[No Abstract] [Full Text] [Related]
31. An attempt at isolation and partial characterization of specific antibodies from antithymocyte serum.
Fricová V; Hrubá A; Paluska E; Holdová J
Folia Biol (Praha); 1979; 25(6):353-61. PubMed ID: 42567
[TBL] [Abstract][Full Text] [Related]
32. Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.
Golub ES
Cell Immunol; 1971 Aug; 2(4):353-61. PubMed ID: 4399614
[No Abstract] [Full Text] [Related]
33. Specific inactivation of lymphoid cells in bone marrow grafts.
Müller-Ruchholtz W; Müller-Hermelink HK; Sonntag HG
Transplant Proc; 1973 Mar; 5(1):877-80. PubMed ID: 4144468
[No Abstract] [Full Text] [Related]
34. The biologic significance of Fc receptor on mouse B-lymphocytes.
Paraskevas F; Orr KB; Anderson ED; Lee ST; Israels LG
J Immunol; 1972 Jun; 108(6):1729-32. PubMed ID: 5031328
[No Abstract] [Full Text] [Related]
35. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
Howe M; Berman L; Cohen L
J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
[No Abstract] [Full Text] [Related]
36. [Suppression of antibody formation by bone marrow T-cells activated by histocompatibility antigens].
Gambarov SS; Khaitov RM
Biull Eksp Biol Med; 1977 Mar; 83(3):300-2. PubMed ID: 322761
[TBL] [Abstract][Full Text] [Related]
37. Synergism between lymph node and bone marrow cells for production of granulocytes. I. Requirement for immunocompetent cells.
Kanamaru A; Kitamura Y; Kawata T; Okano K
Exp Hematol; 1974; 2(1):35-42. PubMed ID: 4155687
[No Abstract] [Full Text] [Related]
38. Antilymphocytic activity of rabbit anti-chicken anti-brain sera.
Feiglová E; Pichlíková L; Nouza K
Folia Biol (Praha); 1972; 18(4):256-63. PubMed ID: 5054348
[No Abstract] [Full Text] [Related]
39. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Gozzo JJ; Wood ML; Pompei R; Monaco AP
Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
[No Abstract] [Full Text] [Related]
40. Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice.
Skov CB; Twohy DW
J Immunol; 1974 Dec; 113(6):2004-11. PubMed ID: 4214869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
